Evaluation of the Safety and Efficacy of EXPAREL When Administered by Infiltration Into the Transversus Abdominis Plane (TAP) for Prolonged Postsurgical Analgesia in Subjects Undergoing Robot-assisted

Trial Conditions

Pain

What is the purpose of this trial?

The study of the analgesic affect when infiltrated into the TAP for men undergoing
prostatectomy.

Date & Status

Recruiting

Who can Participate?

Eligibility

Ages:18 - 75

Gender:Male

Eligibility

Inclusion Criteria:

- male subjects, aged 18-75

- ASA physical status 1-3

- Undergoing robot-assisted laparoscopic prostatectomy performed by a single surgeon (Ingolf Tuerk, MD)

- Subjects must be physically and mentally able to participate in the study and complete all study assessments.

- Subjects must be able to give fully informed consent to participate in this study after demonstrating a good understanding of the risks and benefits of the TAP infiltration.

Exclusion Criteria:

- Demonstrated hypersensitivity or idiosyncratic reactions to amide-type local anesthetics.

- Inability to tolerate oxycodone with acetaminophen (e.g. Percocet)

- Any subject whose anatomy or surgical procedure in the opinion of the Investigator might preclude the potential successful performance of a TAP.

- Any subject who in the opinion of the Investigator might be harmed or be a poor candidate for participation in the study.

- Subjects who have received any investigational drug within 30 days prior to study drug administration or planned administration of another investigational product or procedure during their participation in this study.